Not checked for notices yet.
Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world
Tjalf Ziemssen, Katja Thomas
Therapeutic Advances in Neurological Disorders · 2017
Cited by papers we hold 1
- Molecular biomarkers in multiple sclerosis · 2019No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.